World Specialty Silicas

World demand to reach 2.7 million metric tons in 2016

World demand for specialty silicas -- which include precipitated silica, fumed silica, silica gel, and silica sol -- will increase at a healthy pace to 2.7 million metric tons in 2016. Robust growth in rubber applications -- the largest market for specialty silicas -- will drive gains, particularly in the expanding industrial sectors of developing countries such as China and India.

Silica will also register strong gains in demand in the chemicals market as more products employ silica additives to improve performance. Growth in the food and feed market will be restrained by market maturity in developed countries, though demand will still be moderate as
more processed food is used in developing countries. The cosmetics and toiletries market for silicas will also see more limited gains, as the usage of silica in toothpaste is becoming increasingly mature. However, increasing personal consumption expenditures in developing countries, especially China, will continue to support growth.

Strong turnaround in rubber industry to benefit specialty silica consumption

A strong turnaround in the world rubber industry, which was hard-hit by the 2008- 2009 economic downturn, will benefit silica demand. Through 2016, the fastest gains in volume terms will be seen for fumed silica, fueled by a rebound in the production of silicone rubber for industrial rubber applications as the economy recovers. Precipitated silica demand will also be bolstered by strong gains in nontire rubber products.

Get your copy of this report @http://www.reportsnreports.com/reports/163745-world-specialty-silicas-to-2016.html

Report Details:

Published: July 2012
No. of Pages: 303 

Price: US$6100

Adoption of “green tires” to boost specialty silica value & volume demand

A major force impacting market demand in both value and volume terms will be the adoption of “green tires,” which use precipitated silica to lower rolling resistance and improve motor vehicle fuel economy. Popular in Western Europe, “green tires” are beginning to gain traction in other parts of the world as consumers seek out environmentally friendly and fuel efficient tires. Growth will continue in Western Europe with mandatory tire labeling based on fuel efficiency and other characteristics. However, as the “green tire” market in Europe approaches market maturity, advances in demand will take place in North America, Japan, and developing countries, where tire-labeling regulations are also being considered. Due to the size of the “green tire” market, precipitated silica will remain the dominant product type through 2016.

Semiconductor polishing to lead gains in industrial processing market

The industrial processing market will experience moderate growth, though more rapid increases will exist in the semiconductor polishing segment. As semiconductor device density increases,
silica sol, which has smaller particle size and less tendency to form clumps, will be adopted in chemical mechanical planarization (CMP) slurries, a factor in silica sol’s quickly accelerating growth rate. Rapid gains in the paper market will also drive silica sol growth. Applications such as cosmetics and cat litter will have reached maturity in developed markets, restraining growth for silica gel.

COMPANY PROFILES

Profiles for global competitors such as Cabot, Evonik Industries, PPG, Rhodia (Solvay), Wacker Chemie and WR Grace

Tissue and Hygiene in Guatemala

Overview

Discover the latest market trends and uncover sources of future market growth for the Tissue and Hygiene industry in Guatemala with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Tissue and Hygiene industry in Guatemala, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Guatemala for free:

• Away-from-home tissue and hygiene
• Cotton wool, buds, and pads
• Incontinence
• Kitchen towels
• Nappies, diapers, and pants
• Paper tableware
• Sanitary protection
• Tissues
• Toilet paper
• Wipes

The Tissue and Hygiene in Guatemala market research report includes:

• Analysis of key supply-side and demand trends
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Tissue and Hygiene in Guatemala?
• What are the major brands in Guatemala?
• What are the most dynamic tissue and hygiene categories?
• What are the major markets for tissue products sales?
• What are the major markets for hygiene products sales?

Why buy this report?

• Gain competitive intelligence about market leaders
• Track key industry trends, opportunities and threats
• Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Tissue and Hygiene market research database.

Sample Analysis

EXECUTIVE SUMMARY

Healthy value growth is recorded in tissue and hygiene during 2011
2011 was a good year for tissue and hygiene in Guatemala. Value sales increased in all categories as many of the products categorised under tissue and hygiene in Guatemala are used on a daily basis. Guatemala’s urban areas account for by far the majority of tissue and hygiene users as the higher disposable incomes of Guatemala’s urban dwellers means that they purchase more tissue and hygiene products and tend to opt for higher quality products when doing so.

Retail tissue and hygiene is a very dynamic category in Guatemala
The entrance of more efficient tissue and hygiene products with value added properties and strong advertising campaigns undertaken by the country’s leading tissue and hygiene companies has led to tissue and hygiene in Guatemala becoming a dynamic industry. As the consumer base for tissue and hygiene continues to widen due to increasingly rapid urbanisation and rising disposable incomes as more women join Guatemala’s workforce, the companies which are present in tissue and hygiene in Guatemala continue to innovate and introduce products offering benefits which will attract higher numbers of consumers.

International companies continue to lead tissue and hygiene
The presence of international companies remains strong in tissue and hygiene in Guatemala. Many international brands have a longstanding presence in the country, which allows them stronger brand recognition and higher levels of consumer loyalty. These international companies tend to engage in the most interesting advertising campaigns and a high degree of new product development, allowing them access to more consumer attention. Domestic brands are also present in tissue and hygiene in Guatemala, but these brands usually compete by offering basic low-quality products to price-sensitive low income consumers.

Stronger distribution chains needed in tissue and hygiene in Guatemala
Guatemala is a small country, but one with a high percentage of the population living in rural areas. These rural consumers usually have low disposable incomes and the presence of tiendas de barrio—community-centred retail outlets categorised under independent small grocers—is very important. Independent small grocers accounted for 44% of total tissue and hygiene retail value sales in 2011. The companies distributing their tissue and hygiene products through this channel need to have strong distribution chains in order to reach the many outlets in remote locations. Even though there are more supermarkets being opened in rural areas of Guatemala, they are not yet present in small towns, where independent small grocers continue to dominate the retailing landscape.

Stronger growth expected in tissue and hygiene during the forecast period
It is expected that tissue and hygiene in Guatemala will register stronger volume growth terms during the forecast period than the volume growth which was recorded during the review period. The main driver of volume growth over the forecast period is set to be the wider consumer base for tissue and hygiene due to population growth and rising disposable income levels. The companies which operate in tissue and hygiene in Guatemala face a massive challenge during the forecast period: to increase use of tissue and hygiene among Guatemalans as the per capita use of products such as nappies/diapers and incontinence products is among the lowest in Latin America. The introduction of smaller pack sizes is playing a positive role in increasing consumption of tissue and hygiene as these smaller products carry lower retail selling prices and are therefore seen as more affordable for Guatemalan consumers.

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181615-tissue-and-hygiene-in-guatemala.html

Report Details:
Published: July 2012
Price: Single User License- US $2400             
                                  

Case Study: Personalized Cancer Therapy - Anticipated competition threatens to dampen commercial potential of new approvals

The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the pharmaceutical industry to search for disease and patient characteristics which confer the best response rates. Identification of biomarkers and companion diagnostics will pave the way for personalized cancer therapy.

Features and benefits

• In-depth analysis of companion diagnostic development – when to start development, internal or partnership development, with case study examples
• In-depth analysis of personalized cancer therapy commercial potential – with patient population analysis and case studies
• In-depth analysis of US, EU, and Japanese current and developing regulatory processes for personalized cancer therapy
• Extensive analysis of Zelboraf and Xalkori, including seven major market sales forecasts 2011-21 and detailed development timelines

Highlights
Pharmaceutical companies face a number of important decisions regarding personalized therapy development. Selecting the correct time to begin companion diagnostic development will help improve the chances of approval and drive new drug uptake. Developers must also assess their position in the market before choosing internal or external development.

The development of BRAF inhibitor resistance and anticipated launch of GlaxoSmithKline’s two personalized therapies will undoubtedly impact Zelboraf’s commercial potential. The question remains as to whether a small subgroup of patients in one indication can commercially support two almost identical drugs.

Regulators have now realized that the regulatory framework must be altered to incorporate both drugs and companion diagnostics. The US, EU and Japanese authorities are all starting to change their guidelines to encourage personalized therapy development. However, there are still hurdles to overcome before co-development becomes common practice.

Your key questions answered

• Gain extensive insight into the clinical and commercial aspects of Zelboraf and Xalkori, including 2011-21 forecasts
• Identify key decisions when developing a drug and companion diagnostic, including internal or external development and when to start development
• Assess the changes in regulatory processes in the seven major markets as the paradigm of personalized cancer medicine grows

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181601-case-study-personalized-cancer-therapy-anticipated-competition-threatens-to-dampen-commercial-potential-of-new-approvals.html


Report Details:
Published: July 2012
No. of Pages: 71
Price: Single User License- US $1900                Corporate User License- US $ 4750
                                  

Table Of contents

OVERVIEW
Catalyst
Summary

EXECUTIVE SUMMARY
Strategic scoping and focus
Datamonitor key findings
Related reports

INTRODUCTION
Oncology overview
A move toward personalized therapy with the development of targeted drugs

BIOMARKERS
Oncology biomarkers
Definition
Classification of cancer biomarkers
Targeted therapies and predictive biomarkers

DRUG AND COMPANION DIAGNOSTIC DEVELOPMENT
Case study
Iressa (gefitinib; AstraZeneca)
Development approach
Overview
When to develop companion diagnostics
Internal or external companion diagnostic development

COMMERCIAL POTENTIAL
Patient population
(Untitled sub-section)
Herceptin (trastuzumab; Roche/Genentech/Chugai)
Erbitux (cetuximab; Bristol-Myers Squibb/Eli Lilly/Merck KGaA) and Vectibix (panitumumab; Amgen)
Cost-effectiveness
Companion diagnostics make cancer treatments more cost-effective
Reimbursement
Reimbursement policies must consider personalized cancer therapy

REGULATORS
Regulators and personalized cancer therapy
Regulations are changing to encourage companion diagnostic co-development
US regulatory authorities
EU regulatory authorities
Japanese regulatory authorities

KEY MARKETED PERSONALIZED CANCER THERAPIES
Zelboraf (vemurafenib; Roche/Daiichi Sankyo)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Development path
Commercial potential
Clinical and commercial assessment
Xalkori (crizotinib; Pfizer)
Drug profile
Drug overview
Companion diagnostic overview
Development path
Commercial potential
Clinical and commercial potential

KEY PIPELINE PERSONALIZED CANCER TERAPIES
Dabrafenib (GSK-2118436; GlaxoSmithKline)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Market potential
Trametinib (GSK-1120212; GlaxoSmithKline)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Market potential
Tomtovok (afatinib; Boehringer Ingelheim)
Personalized therapy profile
Drug overview
Companion diagnostic overview
Market potential
Other pipeline personalized cancer therapies
Overview of other pipeline personalized cancer therapies

BIBLIOGRAPHY
Journals
Websites
Datamonitor reports
Other

APPENDIX
Forecast methodology
Volume and value forecast methodology
Price assumptions
Contributing experts
Report methodology

List Of Tables
Table: Biomarker classification according to modality
Table: Examples of available companion diagnostics for targeted cancer therapies, 2012
Table: Approved cancer drugs with biomarkers on label, 2012
Table: Iressa: key historical events, 1994–2010
Table: Pharmaceutical company acquisitions of diagnostic companies, 2012
Table: Examples of diagnostic and pharmaceutical company partnerships for cancer therapies, 2010–12
Table: FDA-approved HER2 diagnostic tests, 2012
Table: FDA- and EMA-approved drugs with mandatory biomarker tests, 2012
Table: Zelboraf – drug profile, 2012
Table: Zelboraf sales forecast, by country ($m), 2011–21
Table: Xalkori – drug profile, 2012
Table: Xalkori sales forecast, by country ($m), 2011–21
Table: Dabrafenib – drug profile, 2012
Table: Trametinib – drug profile, 2012
Table: Tomtovok – drug profile, 2012
Table: Key pipeline personalized cancer therapies


Contact sales@reportsandreports.com for further details.

Software Testing for CSPs - Market Analysis

This 60-page report presents the results of our extensive primary research into the demand and supply of independent software testing services within communications service providers (CSPs) around the world.

Our analysis gives never before published market information including trends, drivers, market sizing and competitive analysis in the software testing segment based on direct customer and supplier interviews.

The main subjects covered by this report include:

• Analysis of the current communications service provider requirements for independent software testing services
• Definition of the market drivers and trends and how they impact on demand for services
• Competitive landscape, including identification of the major providers, their market positioning, strengths and weaknesses, and the fit of their offers to customer requirements
• Independent telecom software testing market size and forecast by region from 2011-2016, and share of the market leaders

The research involved telephone interviews and online surveys with the top testing providers as well as communications service providers on all continents, covering the fixed, mobile, media and Internet segments.

This report is an invaluable source of information for telecom testing executives worldwide seeking to establish how and where the world's independent telecom software testing market is expected to grow over the next 5 years, where the industry is heading in the coming years and what services and support customers are expecting.
Analysis of the current communications service provider requirements for independent software testing services.

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181604-software-testing-for-csps-market-analysis.html

Report Details:
Published: June 2012
No. of Pages: 60
Price: Single User License- US $2000              
                                  

Global Markets and Technologies for Carbon Nanotubes

REPORT HIGHLIGHTS

• The global market for various carbon nanotubes (CNT) grades was $192 million in 2011. In 2012, it is estimated to generate nearly $239 million in revenues, and projected to grow over the next five years at a compound annual growth rate (CAGR) of 22.4%, reaching $527 million by 2016.
• The global market for multi-walled carbon nanotubes (MWNTs) is estimated to rise from $219 million in 2012 to $292 million in 2016, a CAGR of 9.1% between 2011 and 2016.
• The global market for few-walled carbon nanotubes (FWNTs) is estimated to reach $1.8 million in 2012 and $120 million in 2016, a CAGR of 131.6% between 2011 and 2016.

REPORT SCOPE

INTRODUCTION

MOTIVATION

Among the numerous categories in the evolving field of newly synthesized nanomaterials, carbon nanotubes (CNTs) are perhaps among the most dynamic and undergoing the most rapid pace of development.  The past five years have witnessed relentless growth in the research, development and technological understanding of these remarkable materials.  Universities, small businesses and start-ups, as well as large corporations, have continued to probe and exploit numerous commercial possibilities for these fascinating materials.  As a result, the list of product applications is expanding considerably and is projected to do so well into the future.

The most tangible evidence for growth and interest is reflected by the emergence of new CNT producers now capable of offering CNTs in commercial-scale quantities—in kilograms, tonnes and even hundreds of tonnes, depending on the specific grade—at more affordable and increasingly competitive unit pricing.  In addition, after several years of incubation, there is a new breed of more mature university spin-offs, or nanotechnology companies, targeting specific application sectors.  Additional evidence of growth is the increasing presence of larger, more established corporations that recognize the future market opportunities offered by CNTs.  Finally, over the past five years, there has been phenomenal growth in patent activity.  In 2010 alone, the number of issued CNT-related U.S. patents reached 1,585, an increase of 54% over the previous year. In 2011, this increased more moderately, by 7.7%, but nonetheless reached an annual output record of 1,707.  For patents pending, the situation is even more dramatic, with a cumulative backlog from 2001 to 2011 now totaling 16,775. For the current review period (2010 to 2011 total output alone reached 54% of the previous period (2001 to 2009).

In view of the technical momentum—representing a multibillion-dollar technology investment—and the enormous business potential, this report provides a timely update on CNTs—their level of technical maturity, where they are starting to penetrate the marketplace, and when and where the broadening market unravels.

OBJECTIVES AND PURPOSE OF THIS REPORT

The primary objectives of this report are threefold:

• Assess the current state-of-the-art in CNT production and technical applications understanding.
• Identify the current players seeking to exploit their unique properties.
• Evaluate actual or impending markets in terms of the technical readiness of CNTs and the projected market revenues.

SCOPE OF REPORTThis updated report is divided into the following nine major chapters:

CHAPTER THREE—TECHNOLOGY OVERVIEW defines, outlines the history, describes the production methodology, identifies the unique properties of various forms of CNTs and emphasizes the major application challenges.

CHAPTER FOUR—PATENT ANALYSIS provides an extensive search/analysis of U.S. issued and pending patents (along with Canadian, European and WPTO databases where there is no USPTO presence), a collation of the main technical/application sectors and identifies the most active organizations—U.S. and foreign—driving CNT technology.

CHAPTER FIVE—INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS identifies current producers, progress in continuous production scale-up, market segmentation and an industry profile covering the major players.

CHAPTER SIX—MARKETS BY APPLICATION represents the body of the report assessing the latest progress and technical readiness in the major application sectors of composites, electronics, energy storage, membranes, sensors and other applications.

CHAPTER SEVEN—GLOBAL MARKET ANALYSIS estimates five-year potential revenues of all notable CNT producers.

CHAPTER EIGHT—NORTH AMERICAN MARKET ANALYSIS estimates five-year potential revenues of U.S. and Canadian CNT producers.

CHAPTER NINE—EUROPEAN MARKET ANALYSIS estimates five-year potential revenues of European CNT producers.

CHAPTER TEN—ASIAN MARKET ANALYSIS estimates five-year potential revenues of Asian CNT producers.

CHAPTER ELEVEN—MARKET PULL: PROGNOSIS FOR GLOBAL CNT APPLICATIONS identifies the most promising applications realizable based on the leading proponents, technical readiness and market interest.

CONTRIBUTION OF THE STUDY AND TARGET AUDIENCE
This report represents a major update to BCC Research’s report, Carbon Nanotubes: Technologies and Global Markets, NAN024D, published in January 2010.  The most significant revisions in this new edition include the following:

• An extensive patent analysis of the U.S. patent database.
• An in-depth assessment of the unfolding commercial markets.
• Progress in the synthesis and commercial scale-up of CNTs.
• Extensive compilation of the producers and end users dictating market development.
• A five-year projected market analysis of the emerging CNT industry.

This comprehensive technical and business assessment on the current status of the CNT industry should prove informative to nanomaterials manufacturers, investors seeking near-term commercialization opportunities, technologists confronted with nanomaterial device integration issues and companies interested in exploiting revolutionary nanomaterials for advanced composites, biomedical, electronic, energy storage, membranes/separation, sensing, security and other emerging applications.

METHODOLOGY AND SOURCES OF INFORMATION
This report is primarily derived from the enormous amount of patent and technical literature relating to CNTs disclosed in the public domain.  In addition, complementary information has also been drawn from the business community, such as company investment news, company profiles, press releases and personal telephone interviews with selected companies.

AUTHOR’S CREDENTIALS
John Oliver, the author of this report, is the founder of Innov8 Solutions, which provides advanced materials consultation services to industrial clients.  He has more than 30 years of industrial R&D experience in surface and colloid science spanning a wide range of materials technology.  Primarily, working as a senior scientist at Xerox Research Centre of Canada, he developed an invaluable understanding in advanced materials used in digital printing technologies such as xerography and ink-jet printing (IJP).  In the past 10 years through his involvements with the Alberta Research Council and several Alberta universities, his interests have evolved into the realm of nanomaterials and microsystems device integration.  He has a Ph.D. in Physical Chemistry from McGill University, and a BSc degree in Chemistry from Surrey University, U.K.  His publications include more than 40 technical peer-reviewed technical articles and 20 patents. Between 2005 and 2009, he was the editor of BCC’s monthly Nanoparticle News and has authored five previous BCC Research’s nanomaterial technical reports, Quantum Dots: Technical Status and Market Prospects (GB-278, NAN027B/NAN027C) and Carbon Nanotubes: Technologies and Commercial Prospects (NAN024C, NAN024D).

Buy your copy of this reports @ http://www.reportsnreports.com/reports/181591-global-markets-and-technologies-for-carbon-nanotubes.html


Report Details:
Published: July 2012
No. of Pages: 398

Price: Single User License- US $4850                Corporate User License- US $ 8500